Optimized dosing of spatially heterogeneous radiopharmaceutical therapy reprograms poorly immunogenic tumors…

644 Combining radiopharmaceutical ligand therapy with CAR T cells to overcome the heterogeneous immunosuppressive prostate tumor microenvironment
Shuai Yang, Tanya Dorff, Jiangyue Liu +22
Journal for ImmunoTherapy of Cancer5 Nov 2026Peer-reviewedCC BYFull textMedical imaging & radiologyDOAJ
An Aliquoting Strategy for Commercial Gallium-68 Radiopharmaceutical Cold Kits
Jade Torchio, Marine M Cadet, Stephane C Renaud +2
Journal of visualized experiments : JoVE3 Nov 2026Peer-reviewedPublisher termsFull textSystems & synthetic biology Inorganic & organometallic chemistryHAL
Loco-regional radiopharmaceutical therapy in breast carcinoma using [177Lu]Lu-microseed implants: Development to proof-of-concept
Sejal Chopra, Aarti Aggarwal, Komalpreet Kaur +8
Scientific Reports5 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textMedical imaging & radiologyCrossref
Current state and future potential of radiopharmaceutical therapy in breast cancer
Joyce O'Shaughnessy, Neil K. Taunk, Gary A. Ulaner
Breast17 Oct 2026Peer-reviewedCC BY 4.0Full textMedical imaging & radiologyDOAJPMC
Radiation-Induced Remodeling of Bone Metastases and the Bone Marrow Microenvironment: From External-Beam Radiotherapy to Radiopharmaceutical Therapy
Satoru Monzen, Akihito Kotani, Masaki Tatara +4
Cancers30 Oct 2026Peer-reviewedCC BY 4.0OncologyCrossref

Cite

BibTeX

@misc{takashima2026optimized,
  title = {{Optimized dosing of spatially heterogeneous radiopharmaceutical therapy reprograms poorly immunogenic tumors to enhance response to immune checkpoint blockade}},
  author = {M. E. Takashima and Z. Danaceau and M. Bio Idrissou and O. Kwon and T. J. Berg and P. A. Clark and Y. Wang and W. Jin and A. O. Adeniyi and C. Donnelly Haasch and M. Antonelli and J. Weichert and B. Bednarz and R. T. Hernandez and I. Ong and Z. S. Morris},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.27.762270},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.27.762270v1},
}

RIS

TY  - UNPB
TI  - Optimized dosing of spatially heterogeneous radiopharmaceutical therapy reprograms poorly immunogenic tumors to enhance response to immune checkpoint blockade
AU  - M. E. Takashima
AU  - Z. Danaceau
AU  - M. Bio Idrissou
AU  - O. Kwon
AU  - T. J. Berg
AU  - P. A. Clark
AU  - Y. Wang
AU  - W. Jin
AU  - A. O. Adeniyi
AU  - C. Donnelly Haasch
AU  - M. Antonelli
AU  - J. Weichert
AU  - B. Bednarz
AU  - R. T. Hernandez
AU  - I. Ong
AU  - Z. S. Morris
PY  - 2026
DA  - 2026/10/27
PB  - bioRxiv
DO  - 10.64898/2026.10.27.762270
UR  - https://www.biorxiv.org/content/10.64898/2026.10.27.762270v1
SN  - 2692-8205
ER  -

Related

Cite